Tapentadol is partially metabolized with the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medications that boost or repress the exercise/expression of one or more of such enzymes, as well as with substrates of those enzymes (resulting from Competitors for your enzyme); some enzyme mediators/substrates demand https://winstons234bsh5.mysticwiki.com/user